Insider holders · CIK 0001708599
Serina Therapeutics, Inc. · SER
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Juvenescence Ltd10% Owner | 16,400,000 | — | 16,400,000 | Nov 27, 2018 · 6:29 pm EST | Form 3 |
| Gregory BaileyDirector | 8,564,382 | — | 8,564,382 | Jun 22, 2026 · 7:14 pm EDT | Form 4 |
| Jay VenkatesanDirector | 589 | 231,705 | 232,294 | Jun 22, 2026 · 7:15 pm EDT | Form 4 |
| Judith SegallCorporate Secretary | 52,624 | — | 52,624 | Feb 14, 2019 · 9:06 pm EST | Form 5 |
| Karen J WilsonDirector | 30,100 | — | 30,100 | Jun 22, 2026 · 7:13 pm EDT | Form 4 |
| Michael D WestChief Executive Officer | 17,051 | — | 17,051 | Feb 14, 2019 · 9:37 pm EST | Form 5 |
| Michael H. MulroyDirector | 3,255 | — | 3,255 | Feb 14, 2019 · 8:56 pm EST | Form 5 |
| Stephen K. BrannanDirector | 1,000 | — | 1,000 | Jul 9, 2026 · 12:05 pm EDT | Form 4 |
| Russell SkibstedChief Financial Officer | 935 | — | 935 | Feb 14, 2019 · 9:00 pm EST | Form 5 |
| Hal SternbergVice President-Research | 133 | — | 133 | Mar 13, 2019 · 9:35 pm EDT | Form 4 |
| Annalisa JenkinsDirector | 0 | — | 0 | Nov 27, 2018 · 6:30 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.